Möchten Sie immer auf dem neuesten Stand bleiben?

FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH) HoFH is an inherited condition characterized by extremely high levels of...

TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia TGA Approves NexoBrid® for Adults and Children; Manufacturing Readiness Positions MediWound for 2025 Launch and...

ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday,...

Boston, Sept. 23, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Chromatography in Pharmaceuticals and Biotechnology: Global Markets” is projected to grow from $13.3...

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course (Nov 5th - Nov 7th, 2025)" has been added to ResearchAndMarkets.com's offering. Working in the highly...

In partnership with Mitacs, Applied Pharmaceutical Innovation (API) launched the Life Sciences Placement Program, set to provide 1,000 new internships.

Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo If approved, Dupixent would be the first...

Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Industry in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on the pharmaceutical...

LOS ANGELES, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Lantheus Holdings, Inc., investors ("Lantheus" or the "Company") (NASDAQ: LNTH) investors of a class action representing...